DMTK DermTech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: DMTK

Price (delayed)

$0.644

Market cap

$22.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.09

Enterprise value

$36.48M

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform ...

Highlights
DermTech's EPS has increased by 20% YoY and by 12% from the previous quarter
The net income rose by 14% year-on-year and by 8% since the previous quarter
DermTech's gross profit has surged by 153% QoQ but it has shrunk by 57% YoY
The gross margin has soared by 150% from the previous quarter but it has plunged by 60% YoY
DermTech's equity has plunged by 57% YoY and by 22% from the previous quarter
The quick ratio has contracted by 46% YoY and by 23% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://dermtech.com
Peers: SHC

Key stats

What are the main financial stats of DMTK
Market
Shares outstanding
34.62M
Market cap
$22.3M
Enterprise value
$36.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.39
Price to sales (P/S)
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.39
Earnings
Revenue
$15.3M
EBIT
-$100.89M
EBITDA
-$95.04M
Free cash flow
-$77.88M
Per share
EPS
-$3.09
Free cash flow per share
-$2.39
Book value per share
$1.67
Revenue per share
$0.47
TBVPS
$3.74
Balance sheet
Total assets
$121.93M
Total liabilities
$64.76M
Debt
$54.39M
Equity
$57.18M
Working capital
$48.31M
Liquidity
Debt to equity
0.95
Current ratio
4.59
Quick ratio
4.6
Net debt/EBITDA
-0.15
Margins
EBITDA margin
-621.4%
Gross margin
1.8%
Net margin
-659.6%
Operating margin
-678.2%
Efficiency
Return on assets
-67.9%
Return on equity
-124%
Return on invested capital
-69.9%
Return on capital employed
-93%
Return on sales
-659.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DMTK stock price

How has the DermTech stock price performed over time
Intraday
9.15%
1 week
3.54%
1 month
-6.27%
1 year
-85.43%
YTD
-63.2%
QTD
-8.26%

Financial performance

How have DermTech's revenue and profit performed over time
Revenue
$15.3M
Gross profit
$276,000
Operating income
-$103.74M
Net income
-$100.89M
Gross margin
1.8%
Net margin
-659.6%
DermTech's gross profit has surged by 153% QoQ but it has shrunk by 57% YoY
The gross margin has soared by 150% from the previous quarter but it has plunged by 60% YoY
DermTech's net margin has increased by 18% YoY and by 14% from the previous quarter
DermTech's operating margin has increased by 17% YoY and by 14% from the previous quarter

Growth

What is DermTech's growth rate over time

Valuation

What is DermTech stock price valuation
P/E
N/A
P/B
0.39
P/S
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.39
DermTech's EPS has increased by 20% YoY and by 12% from the previous quarter
The price to book (P/B) is 89% lower than the 5-year quarterly average of 3.6 and 57% lower than the last 4 quarters average of 0.9
DermTech's equity has plunged by 57% YoY and by 22% from the previous quarter
The stock's P/S is 97% below its 5-year quarterly average of 43.9 and 74% below its last 4 quarters average of 5.2
The revenue has increased by 6% since the previous quarter and by 5% year-on-year

Efficiency

How efficient is DermTech business performance
The return on equity has dropped by 78% year-on-year and by 13% since the previous quarter
DermTech's return on invested capital has increased by 30% YoY and by 2.2% QoQ
The company's return on assets fell by 24% YoY and by 4% QoQ
DermTech's ROS has increased by 18% YoY and by 14% from the previous quarter

Dividends

What is DMTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DMTK.

Financial health

How did DermTech financials performed over time
The total assets is 88% greater than the total liabilities
DermTech's current ratio has decreased by 47% YoY and by 24% QoQ
The quick ratio has contracted by 46% YoY and by 23% from the previous quarter
DermTech's debt is 4.9% less than its equity
The company's debt to equity has surged by 126% YoY and by 25% QoQ
DermTech's equity has plunged by 57% YoY and by 22% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.